Opening of “Innovative Diabetes Medicine” in Thailand

According to the IDF Diabetes Atlas, 537 million people live with diabetes worldwide with type 2 diabetes, and almost half of them are undiagnosed. It is expected that by 2030 this will increase to 643 million and by 2045 it will increase to 783 million.

While the situation of diabetes in Thailand Data from public health statistics reports of the Ministry of Public Health In 2023, there will be 300,000 new patients every year in 2022, an increase from 2012. find screening of new patients in 2023 that screening for diabetes patients in people aged 35 years and older has not been screened.Diabetesup to 5 million people from a national target of 22 million people

Related news:

“Diabetes” is a health problem for Thai people. That’s not very dangerous.

The pharmaceutical industry is growing rapidly. 5.2 million Thai people have diabetes.

Current guidelines for the treatment of diabetes

Prof. Clinician Dr. Chaichan Deerojanawong, President of the Endocrine Society of Thailand He revealed that diabetes has always been an important problem for the Thai people. Especially in a time where people’s lives have become more convenient. As a result, there are more and more people with diabetes every year.

DiabetesIt is caused by abnormalities in the body’s ability to transport glucose into cells due to a lack of insulin and/or insulin resistance. As a result, blood sugar levels rise. Controls blood sugar levels near normal ina patientDiabetes is important to reduce the risk of complications. Diabetes includes kidney failure, blindness, and cardiovascular disease.

There are many ways to take care of diabetes today, including diet control. exercise and the use of drugs to lower blood sugar levels These methods are important in helping to control blood sugar levels within normal limits. But at the same time, adjustments must be made to suit each individual patient because patients have different blood sugar levels and co-factors. Today there are new medicines. That can be an option for effective diabetes care.

New medicine for the treatment of diabetes

In the first period of treatmentDiabetesInsulin injections and sulfonylurea tablets are used to lower blood sugar levels. The main disadvantage of the two groups of drugs above is the occurrence of hypoglycemia and weight gain after treatment. In addition, there are metformin tablets, which do not cause hypoglycemia and weight gain. – there are new modern medicines. which is continuously developed in the treatment of diabetes. Especially in the group that is oral therapy. This is an option for patients who are not comfortable using injection methods, including:

1. GLP-1 Receptor Agonists

GLP-1 receptor agonists work by stimulating the GLP-1 receptor, which is the same hormone that is produced in the intestines in the body. Makes blood sugar levels go down The medicine only works when blood sugar is high. Therefore, it does not increase the risk of hypoglycemia in the blood In addition, it can help with weight loss, which is an important benefit for diabetic patients who have problems with excess weight.

This group of drugs is also useful in reducing the risk of cardiovascular diseases. Therefore, this is a feature that makes GLP-1 Receptor Agonists an attractive alternative. This is especially true for patients who are at high risk of cardiovascular disease.

Recently, GLP-1 Receptor Agonists have evolved from their original form. which is an injection and comes as an oral drug that has the same effectiveness. This is an advance that represents a new innovation that provides more suitable treatment options for patients.

2. SGLT2 inhibitors

SGLT2 inhibitors play a role in controlling blood sugar levels. By blocking the reabsorption of sugar by the kidneys. Causes the body to excrete sugar through urine. This group of drugs does not cause hypoglycemia and is beneficial in reducing the risk of heart disease and slowing down the deterioration of the kidneys. It is considered another option for the treatment of diabetes.

3. DPP-4 Inhibitors

DPP-4 inhibitors work by blocking the DPP-4 enzyme, which is the enzyme that breaks down the GLP-1 hormone in the body. But this group of drugs has no effect on body weight and has no direct effect on reducing the risk of heart disease and kidney disease.

Research progress in Thailand

Clinical research is extremely important to doctors anda patient Especially in the context of Thailand Clinical research that is specific to the Thai population It not only helps to understand needs and problems.Cheerspatients but can also develop more appropriate and effective treatment guidelines

innovationcure diabetesin Thailand at the moment It has impacted patient care by increasing treatment options to suit individual needs. This is considered an important development that should be supported and continuously improved. But these are the only positive developments. It may not be enough to prevent diabetes.

Controlling your diet and exercising regularly is still a key strategy for the prevention and effective treatment of diabetes. Understanding the types and amounts of food consumed Changing lifestyle habits can also help reduce the risk of diabetes complications.

however innovationNew medicines to treat diabetes and eating the right food along with regular exercise are therefore the key to helping manage diabetes in Thailand.